Back to Research Home
MCKMcKesson Corporation
Health Care · Health Care Distributors · Large
$1,000.77−1.14%
As of 23 Oct 2026Mkt cap $108B
Stage 13
WAIT
Fundamentals
47.5/75
Technical
6.3/15
Independent
53.8/90
GCAE viewtechnical state requires waiting rather than entering now
Price
- 1M
- +15.1%
- 3M
- +17.7%
- 6M
- +20.8%
- 1Y
- +25.8%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 26.8xHist median 27.2x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 19.4x
- FCF yield
- 5.2%
Quality
- ROIC
- —
- Operating margin
- 1.3%
- FCF margin
- 1.4%
- Current ratio
- 0.9x
Growth
- Revenue growth
- +12.4%Latest FY YoY
- Revenue CAGR
- +11.2%
- EPS CAGR
- +51.8%
- FCF CAGR
- +9.0%
Capital
- Share-count trend
- −3.8%3Y annualised
- Net debt
- $1.3B0.2x OCF
Annual trend
- CAGR 2022–2026
- +11.2%
- Latest · 2026
- $403B
- YoY
- +12.4%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
technical state requires waiting rather than entering now
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-04
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded